Suppressing SREBP‐1 in HCC cells induces growth arrest and apoptosis, whereas over‐expressing SREBP‐1 enhances cell proliferation, suggesting that SREBP‐1 may be a therapeutic target for HCC.9 Here, SREBF1 is linked to hepatocellular carcinoma.